World’s first licensed naloxone product for use by non-healthcare professional in a community setting
First ever licensed oral liquid suspension of clobazam available in the UK
Martindale Pharma announce a change to distribution of its product portfolio to UK hospitals
Drawtex®, First Product in Portfolio, Launched Today at Wounds UK Conference
New alcohol and chloroform free formulation expected in pharmacies mid to late November.
Extends Critical Care Caffeine range with launch of oral product to improve ease of use.
Martindale Pharma is pleased to announce that the Company has joined the Sunday Times Deloitte Buyout Track 100, as one of the top 100 fastest growing private equity backed companies in 2012
Martindale Pharma is pleased to announce the launch today of Latanoprost 0.005% w/v eye drop solution (2.5ml solution), a first in line treatment for Glaucoma
Martindale Pharma® is pleased to announce that it has launched Methylthioninium chloride Proveblue® for the treatment of medicinal and chemical products.
Martindale Pharma® is pleased to announce that it has introduced a number of significant improvements to its market-leading Aurum Range of eleven pre-filled syringes.
and online ordering
We commit to a 24-hour turnaround on the majority of our specials product range